METHOD FOR DETERMINATION OF ENDOTHELIAL DYSFUNCTION

FIELD: medicine. ^ SUBSTANCE: test with reactive hyperemia according to D.Celermajer is carried out, diameter of brachial artery and peak systolic blood velocity are measured. The measurement is carried out before and in the first 15 seconds of reactive heperemia. Discriminant function (F1(x)) is ca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SHAKHOVA ELENA VIKTOROVNA, IL'INYKH DMITRIJ LEONIDOVICH, LEVASHOV SERGEJ JUR'EVICH, VOLKOVA EHMILIJA GRIGOR'EVNA
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine. ^ SUBSTANCE: test with reactive hyperemia according to D.Celermajer is carried out, diameter of brachial artery and peak systolic blood velocity are measured. The measurement is carried out before and in the first 15 seconds of reactive heperemia. Discriminant function (F1(x)) is calculated: F1(x)=-13.461-1.288*(sex)+0s021*V1+1.271*DeltaD1 (%), where sex: 1 - male; 2 - female; DeltaD1% - increase of brachial artery's diameter in the first 15 seconds of reactive hyperemia; V1, cm/sec - peak systolic velocity in the first 15 seconds of reactive hyperemia; -13.461; -1.280; 0.021; 1.271 - constants, received after statistic discriminant analyse. If F1(x) is more than 0.057, endothelial dysfunction is diagnosed. ^ EFFECT: reliability enhancement of the results. ^ 1 tbl, 2 dwg, 2 ex